MTRNR2L7

Across TCGA pan-cancer cohorts, MTRNR2L7 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MTRNR2L7 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MTRNR2L7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTRNR2L7 expression acts as an unfavorable survival marker, although some lineages such as ACC and BLCA show a favorable association.

UCS, ACC, and LUAD are the cancer types where MTRNR2L7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	II,III,IV	0.089	0.482	<.001	108	view →
ACC	DFS	Median	All	0.640	0.266	<.001	84	view →
LUAD	OS	Tertile	III,IV	0.336	0.707	.001	75	view →
CESC	OS	Tertile	III,IV	0.099	0.487	.002	60	view →
STAD	OS	Median	III,IV	0.552	0.703	.009	36	view →
COAD	OS	Tertile	IV	0.190	0.670	.011	27	view →
SARC	DFS	Tertile	All	0.154	0.351	.001	18	view →
SKCM	DFS	Tertile	II,III,IV	0.411	0.629	.006	15	view →
BLCA	OS	Tertile	II,III,IV	0.543	0.398	.040	9	view →
READ	OS	Tertile	All	0.308	0.735	.038	9	view →
LGG	DFS	Quartile	All	0.745	0.843	.005	7	view →
LUSC	OS	Tertile	II,III,IV	0.644	0.354	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MTRNR2L7–UCS (DFS)

Open the UCS breakdown →